呼吸抑制(Respiratory Depression):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017613)
◆英語タイトル:Respiratory Depression-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017613
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[呼吸抑制(Respiratory Depression):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界における呼吸抑制(Respiratory Depression)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、呼吸抑制(Respiratory Depression)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・呼吸抑制(Respiratory Depression)の概要

・呼吸抑制(Respiratory Depression)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・呼吸抑制(Respiratory Depression)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・呼吸抑制(Respiratory Depression)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Respiratory Depression-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Respiratory Depression. This report provides information on the therapeutic development based on the Respiratory Depression dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Respiratory Depression
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Respiratory Depression pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Respiratory Depression and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Respiratory Depression
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Respiratory Depression pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Respiratory Depression Overview
• Respiratory Depression Pipeline Therapeutics
• Respiratory Depression Therapeutics under Development by Companies
• Respiratory Depression Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Respiratory Depression Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Respiratory Depression Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Respiratory Depression Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Respiratory Depression – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Respiratory Depression – Discontinued Products
• Respiratory Depression – Dormant Products
• Companies Involved in Therapeutics Development for Respiratory Depression
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Respiratory Depression, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Respiratory Depression Assessment by Monotherapy Products
• Respiratory Depression Assessment by Combination Products
• Respiratory Depression Assessment by Route of Administration
• Respiratory Depression Assessment by Stage and Route of Administration
• Respiratory Depression Assessment by Molecule Type
• Respiratory Depression Assessment by Stage and Molecule Type
• Respiratory Depression Therapeutics – Discontinued Products
• Respiratory Depression Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Respiratory Depression, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Respiratory Depression Assessment by Monotherapy Products
• Respiratory Depression Assessment by Combination Products
• Respiratory Depression Assessment by Route of Administration
• Respiratory Depression Assessment by Stage and Route of Administration
• Respiratory Depression Assessment by Molecule Type
• Respiratory Depression Assessment by Stage and Molecule Type


*** レポートのキーワード ***

呼吸抑制(Respiratory Depression)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 自動車ステアリングコラムの世界市場2021
    This report studies Automotive Steering Column in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering Leopold Kostal Valeo TRW Magneti Ma …
  • 世界及び中国の2-ニトロ安息香酸市場2009-2019
    Market Research Report on Global and Chinese 2-Nitrobenzoic acid Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese 2-Nitrobenzoic acid industry. The report firstly reviews the basic information of 2-Nitrobenzoic acid including its classification, application and …
  • シリアルバー(食品)市場動向(~2017):イタリア
    Synopsis The report presents detailed data on consumption trends in the Cereal Bars category in Italy, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers & acquisitions (of Bakery & Cerea …
  • アミルアミンの世界市場
    Amylamines Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, un …
  • 放射線情報システム(RIS)の世界市場2016
    Notes:Production, means the output of RIS Radiology Information System Revenue, means the sales value of RIS Radiology Information System This report studies RIS Radiology Information System in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top …
  • ビニルシクロヘキサンの世界市場2014
    Vinylcyclohexane (CAS 695-12-5) Market Research Report 2014 aims at providing comprehensive data on Vinylcyclohexane market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Vinylcyclohexane description, covers its application areas, manufacturing methods, …
  • スキンケア化粧品用包装の世界市場
    In this report, the global Skincare Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenu …
  • スペインの建築用プラスチック製品市場(~2019):市場規模、動向、予測
    The report Plastic Construction Product Market in Spain to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic construction products in Spain. The research includes historic data from 2008 to 2014 and …
  • ヒートポンプの世界市場ー産業および機会分析ー2016-2026:土壌熱源ヒートポンプ、エアトゥエアヒートポンプ、ATWヒートポンプ、ハイブリッドヒートポンプ
    The device used to pull heat from a lower temperature zone and deliver it to a higher temperature zone is known as a heat pump. These heat pumps use refrigerant in closed or open cycle, which acts as an intermediate medium of heat exchange between source and destination. Heat pumps are of various ty …
  • 世界の故障電流制限装置市場2017
    Fault Current Limiter Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017613 )"呼吸抑制(Respiratory Depression):治療薬開発パイプライン動向2014" (英文:Respiratory Depression-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。